TR200001948T2 - Mikobakteri vaccaesinden türetilen kompozisyonlar ve bunların kullanımları için metotlar. - Google Patents

Mikobakteri vaccaesinden türetilen kompozisyonlar ve bunların kullanımları için metotlar.

Info

Publication number
TR200001948T2
TR200001948T2 TR2000/01948T TR200001948T TR200001948T2 TR 200001948 T2 TR200001948 T2 TR 200001948T2 TR 2000/01948 T TR2000/01948 T TR 2000/01948T TR 200001948 T TR200001948 T TR 200001948T TR 200001948 T2 TR200001948 T2 TR 200001948T2
Authority
TR
Turkey
Prior art keywords
methods
delipide
cells
vaccae
compositions derived
Prior art date
Application number
TR2000/01948T
Other languages
English (en)
Inventor
Tan Paul
Watson James
S. Visser Elizabeth
A. Skinner Margot
L.Prestidge Ross
Original Assignee
Genesis Research & Development Corporation Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/997,362 external-priority patent/US5985287A/en
Priority claimed from US08/997,080 external-priority patent/US5968524A/en
Priority claimed from US09/095,855 external-priority patent/US6160093A/en
Priority claimed from US09/205,426 external-priority patent/US6406704B1/en
Application filed by Genesis Research & Development Corporation Limited filed Critical Genesis Research & Development Corporation Limited
Publication of TR200001948T2 publication Critical patent/TR200001948T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Mevcut bulus, mikobakteri vaccaesi içinde ya da bundan türetilen kompozisyonlarla ve bunlarin hastalik tedavisinde kullanimi ve bagisiklik kazanmis hastaliklar ile kanser ve bulasici hastaliklari da içeren düzensizliklerin teshis edilmesi ve bunlarin önlenmesi ile ilgilidir. Antijenler için bagisiklik cevabini artiran metotlar, M. vaccae kültür fitrati, delipide M. vaccae hücreleri, mikolik asidi bosaltilmis delipide ve deglikolipide M. vaccea hücreleri, mikolik asidi ve arabinogalaktani bosaltilmis delipide ve deglikolipide M. vaccae hücrelerini de içermektedir.
TR2000/01948T 1997-12-23 1998-12-23 Mikobakteri vaccaesinden türetilen kompozisyonlar ve bunların kullanımları için metotlar. TR200001948T2 (tr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US99662497A 1997-12-23 1997-12-23
US08/997,362 US5985287A (en) 1996-08-29 1997-12-23 Compounds and methods for treatment and diagnosis of mycobacterial infections
US08/997,080 US5968524A (en) 1997-12-23 1997-12-23 Methods and compounds for the treatment of immunologically-mediated psoriasis
US09/095,855 US6160093A (en) 1996-08-29 1998-06-11 Compounds and methods for treatment and diagnosis of mycobacterial infections
US15618198A 1998-09-17 1998-09-17
US09/205,426 US6406704B1 (en) 1996-08-29 1998-12-04 Compounds and methods for treatment and diagnosis of mycobacterial infections

Publications (1)

Publication Number Publication Date
TR200001948T2 true TR200001948T2 (tr) 2001-02-21

Family

ID=27557521

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/01948T TR200001948T2 (tr) 1997-12-23 1998-12-23 Mikobakteri vaccaesinden türetilen kompozisyonlar ve bunların kullanımları için metotlar.

Country Status (15)

Country Link
EP (1) EP1044273A2 (tr)
JP (1) JP2002514385A (tr)
CN (1) CN1294632A (tr)
AU (1) AU746311B2 (tr)
BR (1) BR9814432A (tr)
CA (1) CA2315539A1 (tr)
HU (1) HUP0100352A2 (tr)
ID (1) ID26327A (tr)
IL (1) IL136821A0 (tr)
MX (1) MXPA00006168A (tr)
NO (1) NO20003261L (tr)
NZ (1) NZ505834A (tr)
PL (1) PL341697A1 (tr)
TR (1) TR200001948T2 (tr)
WO (1) WO1999032634A2 (tr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6569436B1 (en) 1998-10-05 2003-05-27 The Malaghan Institute Of Medical Research Method of using a vaccine
JP4415200B2 (ja) * 1999-01-29 2010-02-17 大塚製薬株式会社 遅発育性抗酸菌ポリペプチド
GB9903539D0 (en) 1999-02-16 1999-04-07 Stanford Rook Ltd Therapy using M.Vaccae
US6350457B1 (en) * 1999-06-02 2002-02-26 Genesis Research & Development Corporation Limited Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
BR0012740A (pt) * 1999-07-12 2002-05-28 Genesis Res & Dev Corp Ltd Compostos para tratamento de distúrbios do sistema infeccioso e imune e métodos para seu emprego
US7217554B2 (en) 1999-08-31 2007-05-15 Novozymes A/S Proteases and variants thereof
NZ531394A (en) * 1999-08-31 2005-10-28 Novozymes As Residual protease II (RPII) and variants thereof useful in detergent compositions
JP2003508054A (ja) * 1999-08-31 2003-03-04 ニーデルバイス，ミヒャエル チャンネル形成性タンパク質の製造方法
US6361776B1 (en) * 1999-12-06 2002-03-26 Genesis Research & Development Corp. Ltd. Compounds isolated from M. vaccae and their use in modulation of immune responses
US20030108527A1 (en) * 1999-12-28 2003-06-12 Tsukasa Seya Maturation-promoting agent for immature dendrtic cells
AUPQ761200A0 (en) * 2000-05-19 2000-06-15 Hunter Immunology Limited Compositions and methods for treatment of mucosal infections
AU2002309857A1 (en) * 2001-05-11 2002-12-03 Corixa Corporation Vaccines for the treatment of autoimmune disease
US20030147861A1 (en) * 2001-07-26 2003-08-07 Genesis Research And Development Corporation Limited Compounds and methods for the modulation of immune responses
AU2002353366A1 (en) * 2001-12-10 2003-06-23 Bakulesh Mafatlal Khamar The process of manufacturing a pharmaceutical composition useful for management of cancer
GB0303507D0 (en) * 2003-02-14 2003-03-19 Novartis Ag Organic compounds
JP6605480B2 (ja) * 2014-01-09 2019-11-13 トランスジェン・ソシエテ・アノニム ヘテロオリゴマーマイコバクテリア抗原の融合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8919321D0 (en) * 1989-08-25 1989-10-11 Univ London Treatment of chronic inflammatory conditions
GB9203814D0 (en) * 1992-02-21 1992-04-08 Univ London Treatment of long term auto-immune conditions
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections

Also Published As

Publication number Publication date
ID26327A (id) 2000-12-14
AU1893699A (en) 1999-07-12
NO20003261L (no) 2000-08-22
CN1294632A (zh) 2001-05-09
WO1999032634A2 (en) 1999-07-01
MXPA00006168A (es) 2005-02-24
PL341697A1 (en) 2001-04-23
JP2002514385A (ja) 2002-05-21
NO20003261D0 (no) 2000-06-22
AU746311B2 (en) 2002-04-18
HUP0100352A2 (hu) 2001-06-28
WO1999032634A3 (en) 1999-12-02
NZ505834A (en) 2002-12-20
IL136821A0 (en) 2001-06-14
EP1044273A2 (en) 2000-10-18
CA2315539A1 (en) 1999-07-01
BR9814432A (pt) 2000-10-10

Similar Documents

Publication Publication Date Title
TR200001948T2 (tr) Mikobakteri vaccaesinden türetilen kompozisyonlar ve bunların kullanımları için metotlar.
DK1187629T3 (da) Adjuvanssammensætning omfattende saponin og et immunostimulerende oligonucleotid
ATE314095T1 (de) Virusähnliche partikel zur induktion von autoantikörpern
ATE315405T1 (de) Cpg-zusammensetzungen, saponin-adjuvantien und verfahren zu deren verwendung
BR0316758A (pt) Vacinas baseadas em levedura como imunoterapia
IL192679A0 (en) Aglyco products and uses thereof
PL332694A1 (en) Purine l-nucleosides, their analoques and their application
ES2192582T3 (es) Composicion de vaccineo, conteniendo quitina, parcialmente deacetilado.
Holvast et al. Influenza vaccination in systemic lupus erythematosus: safe and protective?
ATE306938T1 (de) Verwendung von cpg als adjuvans für hivimpstoff
GB2355983A (en) Method for producing or enhancing a T-cell response against a target cell using a complex comprising an HLA class 1 molecule and an attaching means
ATE418344T1 (de) Fusionszellen und zytokin-zusammensetzungen zur behandlung von krankheiten
FR2717081B1 (fr) Rétropeptides, anticorps dirigés contre ces derniers, et leurs utilisations pour la vaccination et le diagnostic in vitro.
BR0007966A (pt) Composições e métodos para o tratamento e a prevenção de infecção bacteriana patogênica com base na função essencial da metilação do dna na virulência bacteriana
MY127452A (en) Vaccines.
WO1999039693A3 (en) Methods and compositions for detection and diagnosis of infectious diseases
ATE385809T1 (de) Saponin-zusammensetzungen und deren verwendung
AU5489500A (en) Isolation of a human retrovirus
ATE318300T1 (de) Isolierte stämme von staphylococcus aureus und daraus hergestellte impfstoffe
DK1221969T3 (da) Aktivering af antigen-specifikke T-celler med virus/antigen-behandlede dendritiske celler
EP1637166A3 (en) Virus-like particles for the induction of autoantibodies